Tower Research Capital »

Neurogene shares owned by Tower Research Capital

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $20k 1.2k 17.33
2025-06-30 $29k 1.9k 14.95
2025-03-31 $7.8k 670 11.71
2024-12-31 $14k 629 22.86
2024-09-30 $352k 8.4k 41.96